Novartis' Fabhalta showed significant efficacy and safety in a Phase 3 IgA nephropathy study, supporting regulatory filings ...

Novartis has spent considerable time and energy building its presence in the IgA nephropathy (IgAN) disease area, and now | ...

Novartis NVS recently announced positive final results from the late-stage, APPLAUSE-IgAN, study on Fabhalta (iptacopan) in ...

KDIGO's new IgA nephropathy guideline shifts the treatment paradigm from supportive care alone to targeting the disease's immunologic nature.

NASHVILLE, Tenn. — A fully automated artificial intelligence approach predicted post-nephrectomy glomerular filtration rate with comparable accuracy as validated clinical prediction models, according ...

Please provide your email address to receive an email when new articles are posted on . Older adults may have hyperfiltration with normal glomerular filtration rate calculation. GFR calculation may be ...

A prospective population-based cohort study found that glomerular filtration rate based on cystatin C was more sensitive and specific for cardiovascular disease (CVD) and mortality risks compared with ...

Patients with chronic hepatitis B (CHB) have an increased prevalence of chronic kidney disease (CKD), according to a study ...

I recently took a call from a new practitioner. She had an 85-year-old diabetic, non-insulin-dependent female with a glomerular filtration rate (GFR) of 45 mL/min/1.73 m 2. The practitioner asked if ...

Because race is a social construct, not a physical characteristic, the race coefficient may not be needed to calculate eGFR. Removing the race coefficient could increase the number of black ...